journal
https://read.qxmd.com/read/38605429/pregabalin-induced-parkinsonism-case-report-and-review-of-the-literature
#1
JOURNAL ARTICLE
Hossam Tharwat Ali, Sara Abdelhameed Khalil, Ana Leticia Fornari Caprara, Jamir Pitton Rissardo
Pregabalin is an anti-epileptic drug approved for the treatment of neuropathic pain and focal-onset seizures. In a few cases, pregabalin was associated with parkinsonism. We present a case of a 48-year-old female who had hypertension and was on losartan 50 mg/daily. Her general practitioner prescribed pregabalin 150 mg/daily for fibromyalgia-related pain. The subject doubled the dosage without medical advice. After 5 days of the increased dosage, she started to experience difficulty and slowness in movement associated with resting tremors...
April 11, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38597168/premix-versus-on-demand-workflow-models-in-a-veterans-affairs-hematology-oncology-pharmacy-impact-on-estimated-waste-costs-and-patient-wait-time
#2
JOURNAL ARTICLE
Samantha Pan, Anndee Gritte, John Malamakal, Amy Horowitz, Alexa Harris, Sierra J Vig
Background: The balance between reducing patient wait time and mitigating waste of parenteral products has not been well described in literature. Objective: Evaluate the patient wait times and cost-effectiveness of employing a premix versus an on-demand workflow model for compounding parenteral admixtures in a hematology/oncology infusion setting. Methods: This single center, retrospective cost analysis compiled manually documented monthly waste reports and estimated drug pricing for the institution to calculate the cost of waste during both premix and on-demand compounding workflows...
April 10, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38395741/assessing-the-impact-of-posaconazole-cessation-on-tacrolimus-serum-concentrations-and-incident-cardiac-allograft-rejection-take-caution
#3
JOURNAL ARTICLE
Ethan Meyer, Ravi Dhingra, Theodore Berei
Invasive aspergillosis (IA) is a rare and often fatal complication of immunosuppression following orthotopic heart transplant. Prophylaxis plays a crucial role in preventing the emergence of this opportunistic infection. The azole class of medications are the bellwether agents utilized in this patient population. Unfortunately, given their impact on the Cytochrome P450 enzyme system, significant fluctuations in serum tacrolimus concentrations occur when initiating and stopping azole therapy, increasing the risk for prolonged periods of sub-optimal immunosuppression...
February 23, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38387095/immune-thrombocytopenic-purpura-and-intracranial-stenting
#4
JOURNAL ARTICLE
Sophia Pathan
Patients with immune thrombocytopenic purpura (ITP) presenting with indications for dual antiplatelet therapy (DAPT) can be difficult to manage due to the precarious balance of managing the need for increased platelet counts as well as inhibition of platelet activity. This case represents a 65 year old woman with ITP who presented with a bilateral subarachnoid hemorrhage secondary to a left ophthalmic aneurysm that required placement of a pipeline embolization device (PED) necessitating DAPT. After treatment of her ITP with pulse dexamethasone for four days, she was safely discharged on one month of DAPT with aspirin and ticagrelor then switched to aspirin monotherapy without any immediate complications...
February 22, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38380631/understanding-australian-pharmacists-perceptions-on-the-utilisation-of-oral-5-ht3-antagonists-as-pharmacist-only-anti-emetics-in-comparison-to-oral-d2-antagonists
#5
JOURNAL ARTICLE
Aiden Hendry, Jack Janetzki, Wern Chern Chai
Objectives: To investigate the perception of community pharmacists on the down-scheduling of 5-HT3 antagonists to pharmacist-only-medicine for treatment of acute nausea and/or vomiting in Australia. Methods: A nationwide anonymous survey targeting Australian community pharmacists was conducted from April to May 2023. Responses were collected and analysed quantitively or qualitatively, where appropriate. Key findings: Participants reported that 5-HT3 antagonists were effective at treating nausea and/or vomiting and would likely recommend their use...
February 21, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38379309/safety-and-feasibility-of-opening-tamsulosin-capsules-for-enteral-feeding-tube-administration
#6
JOURNAL ARTICLE
Victoria Fazio, Jerry Altshuler, Yong-Bum Song
Purpose: Tamsulosin is formulated as sustained release beads within a capsule to prevent rapid absorption and associated hypotension. The package insert advises the capsule is swallowed whole; not crushed, chewed, or opened. To our knowledge, there are no current data on opening capsules for adults with enteral tube feeds. Given the unidentified safety and efficacy of administration via enteral tubes, alternative alpha blockers with less selectivity for alpha1A are often used. Methods: A single center retrospective chart review was conducted at two hospital sites...
February 20, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38355403/increasing-the-rate-of-venous-thromboembolism-chemoprophylaxis-administration-using-the-electronic-medical-record
#7
JOURNAL ARTICLE
Aaron B Pollock, Kevin N Harrell, M Victoria P Miles, Emily S Garrett, Breanna L Carter, Robert A Maxwell
Introduction: Venous thromboembolism (VTE) remains a leading cause of preventable harm among hospitalized patients. Pharmacologic VTE prophylaxis reduces the rate of in-hospital VTE by 60%, but medication administration is often missed for various reasons. Electronic medical record (EMR) prompts may be a useful tool to decrease withholding of critical VTE chemoprophylaxis medications. Methods: In August 2021, an EMR prompt was implemented at a tertiary referral academic medical center mandating nursing staff to contact a provider for approval before withholding VTE chemoprophylaxis...
February 14, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38262928/the-utah-pharmacy-summit-collaborating-to-optimize-patient-care
#8
JOURNAL ARTICLE
Weston Schmutz, Andre Hejazi, Diana Brixner, Caitlin Arnwine, Jonathan Magness
Pharmacy has evolved significantly over the past 20 years, despite advances in pharmacotherapy and the expanding scope of pharmacy practice, pharmacists have struggled to collaborate across disciplines to create improved processes that enable the best outcomes from these innovations. A lack of innovation at any part of the healthcare system could inhibit the progress of practice innovations thereby leading to suboptimal patient medication and health outcomes. The Utah Pharmacy Summit was held in late 2022 with the goal of promoting pharmacist collaboration and a unified pharmacist voice within the state...
January 23, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38261799/impact-of-lowered-inpatient-correctional-bedtime-insulin-dosing-on-glycemic-outcomes-of-veterans
#9
JOURNAL ARTICLE
Allacyn Hiscox, Jennifer Armbrust, Maria Shin, Jeffrey Bahng
Purpose: This study evaluated glycemic outcomes for hospitalized patients after reduction in bedtime correctional insulin dosing. Methods: This was a retrospective, single-center analysis of a protocol change that reduced bedtime correctional insulin scale. Comparable cohorts pre- and post-protocol change were created which included patients who were ordered correctional insulin with at least 1 blood glucose (BG) reading. The primary outcome was number of nocturnal hypoglycemia readings. Secondary outcomes included, but were not limited to, mean fasting BG, BG within various ranges, and length of stay...
January 23, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38261533/comparison-of-low-dose-recombinant-factor-viia-and-4-factor-prothrombin-complex-concentrate-for-treatment-of-bleeding-related-to-cardiac-surgery
#10
JOURNAL ARTICLE
Lauren Caldwell, Rima Bhakta, Neha Naik, B D Knowles, Jessica Parker, Megan Van Berkel Patel
Background: Recombinant factor VIIa (rFVIIa) and prothrombin concentrate complex (PCC) are used for uncontrolled bleeding in cardiac surgery (CS), however, there are limited direct comparisons of these agents. Objective: To evaluate the efficacy and safety of rFVIIa and PCC in CS related bleeding. Methods: This retrospective study included adult CS patients who received either low dose rFVIIa (<u><</u>30 mcg/kg) or 4-factor PCC. The primary outcome was transfusion requirements of packed red blood cells (pRBC) within 6 hours of factor administration...
January 23, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38241786/exploration-of-norepinephrine-dose-capping-practices-report-from-an-international-interprofessional-survey-of-critical-care-clinicians
#11
JOURNAL ARTICLE
Susan E Smith, Stephen Perona, Scott D Weingart
Purpose: The Joint Commission standards for titrated infusions require specification of maximum rates of infusion. This practice has led to the development of protocolized maximum doses that can be overridden by provider order ("soft maximums") and to dose caps that cannot be superseded ("hard maximums"). The purpose of this study was to determine the prevalence of and attitudes towards dose capping of norepinephrine. Methods: A 20-item cross-sectional survey assessing norepinephrine dose capping practices, perceptions of norepinephrine protocols, and respondent and practice site demographics was distributed electronically to the mailing list of an international medical podcast...
January 19, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38241183/hemostatic-efficacy-and-safety-of-weight-based-versus-fixed-dose-4f-pcc-for-vitamin-k-antagonist-reversal
#12
JOURNAL ARTICLE
Ashley E Milkovits, David Sugrue, Janie Faris, Jessica L Schad, Kelly B McAllister
Background: Four-factor prothrombin complex concentrate (4F-PCC) is indicated for vitamin K antagonist (VKA) reversal but is associated with thrombotic events (TE). In 2018, the institution revised 4F-PCC dosing for VKA reversal from INR and weight-based dosing to a fixed-dose of 1500 units. Objective: The purpose of this study was to compare hemostatic efficacy and TE rate of fixed-dose 4PCC to weight-based dosing. Methods: This was a retrospective, single-center, quasi-experimental study of adult patients who received 4F-PCC for VKA reversal from January 2014 through May 2016 (INR and weight-based dosing) or April through October 2018 (fixed-dosing)...
January 19, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38241151/risk-of-urinary-infections-in-veterans-on-empagliflozin-with-concurrent-catheter-use
#13
JOURNAL ARTICLE
Rachel A Hopper, Danni M McMahan, Kathryn A Jarvis, Rick A Weideman
There has been concern over whether to use sodium-glucose-cotransporter-2 (SGLT-2) inhibitors in patients that use catheters due to the concern for increased urinary tract infections (UTIs). The concern is that patients who use catheters are already at an increased risk for UTIs and that SGLT-2-inhibitors may promote bacterial growth due their mechanism of action, ie. increasing glycosuria. The objective of this study was to evaluate whether using empagliflozin, a SGLT-2-inhibitor, in patients who also use catheters, increases their risks for UTIs...
January 19, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38240733/outcomes-in-variceal-bleeding-associated-with-continuous-octreotide-in-patients-with-delayed-endoscopy
#14
JOURNAL ARTICLE
Matthew B Laws, Rebekah Wahking, Erin Blackburn, Whitney Williams, Aric Schadler, Megan Kunka Fritz
Background: Variceal hemorrhage treatment includes endoscopy within 12 hours of admission and octreotide therapy for 2-5 days post-endoscopy. Duration of pre-endoscopy octreotide can be prolonged when intervention is delayed. Objective: This study aimed to evaluate the impact of extended pre-endoscopy octreotide on rebleeding after endoscopy when comparing short vs long durations of post-endoscopy octreotide. Methods: This was a single center, retrospective cohort evaluating adult cirrhotic patients with esophageal variceal hemorrhage admitted between July 1, 2017 and June 30, 2020...
January 19, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38240599/hydroxychloroquine-induced-hypoglycemia-in-a-patient-without-diabetes
#15
JOURNAL ARTICLE
Madison Mcknight, B Tate Cutshall, Sami Sakaan, Nisreen Abu Al Hommos, Drew A Wells
Hydroxychloroquine is a disease-modifying antirheumatic drug commonly used in the treatment of autoimmune diseases. Although rare, hydroxychloroquine is associated with hypoglycemia in patients with or without diabetes due to its ability to alter insulin metabolism. There have been several cases described in the literature, but none of which, to our knowledge, detail follow-up and time to resolution of hypoglycemia. We describe a 55-year-old female who presents for episodes of hypoglycemia. She reported hypoglycemic symptoms and fasting blood glucoses in the 60-70s mg/dL regularly...
January 19, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38238922/evaluation-of-antibiotic-allergy-in-the-ambulatory-setting-using-a-standardized-questionnaire
#16
JOURNAL ARTICLE
Sarah M Yi, Mary Barsanti-Sekhar, Amy W Wozniak, Maressa Santarossa, Jenna Adams, Fritzie Albarillo
Patients are sometimes mislabeled as having an immune-mediated antibiotic allergy in their medical records. Therefore, the aim of this study was to investigate the prevalence of subjects with non-immune mediated reactions to antibiotics using a standardized questionnaire. Subjects aged 18 years and older with a documented antibiotic allergy were identified and recruited from 2 outpatient clinics in the greater Chicago area. Subjects completed a standardized questionnaire during a single visit regarding their previous adverse reaction to an antibiotic...
January 18, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38237603/cardiovascular-safety-of-amphetamine-dextroamphetamine-versus-methylphenidate-in-older-adults
#17
JOURNAL ARTICLE
Rachel Paulmann, Randi Stouffer, Monica Mathys, Rick Weideman, Carlos Alvarez, Hui Yang
Background: Recent epidemiological data has shown a sharp increase in stimulant use among older adults, which is notable as older adults may be especially vulnerable to their cardiovascular effects. Results of recent studies have shown an increase in cardiovascular events among older adults using stimulants; however, little data exists comparing cardiovascular safety of these agents head-to-head. Objective: To determine if the incidence of serious cardiovascular events, including myocardial infarction (MI), stroke/transient ischemic attack (TIA), or arrhythmia, are different in patients taking amphetamine/dextroamphetamine compared with patients taking methylphenidate...
January 18, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38237567/elevated-anti-xa-in-the-setting-of-prophylactic-unfractionated-subcutaneous-heparin-administration
#18
JOURNAL ARTICLE
Tatiana Weinstein, Diana Altshuler, Elyse Lafond, Alyson Katz
Venous thromboembolism prophylaxis with subcutaneous unfractionated heparin or low molecular weight heparin is a common practice in hospitalized patients. Typically, prophylactic doses of these medications have poor bioavailability and thus do not reach therapeutic serum concentrations. However, in certain circumstances, heparin binding proteins may become saturated. Here we report a case series of 5 patients who had elevated anti-Xa levels while receiving prophylactic dosing of subcutaneous unfractionated heparin...
January 18, 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38355407/acknowledgment-to-reviewers-2023
#19
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 2024: Journal of Pharmacy Practice
https://read.qxmd.com/read/38247339/valacyclovir-neurotoxicity-in-patients-with-end-stage-renal-disease-two-cases-reviewed
#20
JOURNAL ARTICLE
Bernadette Gublo, Amy Beth St Amand, Anupama Menon, Alissa A Scalise
Purpose: The objective of this case series is to highlight different manifestations of valacyclovir associated neurotoxicity (VAN) and demonstrate the importance of adjusting medication appropriately in patients with end-stage renal disease (ESRD) on hemodialysis to prevent these complications. Summary: Valacyclovir is a medication used to treat herpes zoster infection, commonly known as shingles. Valacyclovir is renally cleared and can accumulate in patients with renal dysfunction leading to severe side effects due to the prolonged half-life...
February 2024: Journal of Pharmacy Practice
journal
journal
30014
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.